Conecte-se

Bibliografias temáticas / Pulmonary Pathophysiology / Artigos de revistas

Siga este link para ver outros tipos de publicações sobre o tema: Pulmonary Pathophysiology.

Artigos de revistas sobre o tema "Pulmonary Pathophysiology"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 19 de fevereiro de 2022

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Pulmonary Pathophysiology".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.

1

Cherniack, Neil S. "Pulmonary Pathophysiology." Annals of Internal Medicine 131, no. 5 (September 7, 1999): 399. http://dx.doi.org/10.7326/0003-4819-131-5-199909070-00022.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Gonzalez, Norberto C. "PULMONARY PATHOPHYSIOLOGY." Shock 11, no. 2 (February 1999): 152. http://dx.doi.org/10.1097/00024382-199902000-00018.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Grippi, Michael A. "PULMONARY PATHOPHYSIOLOGY." Shock 5, no. 4 (April 1996): 311. http://dx.doi.org/10.1097/00024382-199604000-00013.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Chamarthy, Murthy R., Asha Kandathil, and Sanjeeva P. Kalva. "Pulmonary vascular pathophysiology." Cardiovascular Diagnosis and Therapy 8, no. 3 (June 2018): 208–13. http://dx.doi.org/10.21037/cdt.2018.01.08.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Gao, Yuansheng, and J. Usha Raj. "Pathophysiology of Pulmonary Hypertension." Colloquium Series on Integrated Systems Physiology: From Molecule to Function 9, no. 6 (November 22, 2017): i—104. http://dx.doi.org/10.4199/c00158ed1v01y201710isp078.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

Angerio, Allan D., and Peter A. Kot. "Pathophysiology of pulmonary edema." Critical Care Nursing Quarterly 17, no. 3 (November 1994): 21–26. http://dx.doi.org/10.1097/00002727-199411000-00004.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Higenbottam, Tim. "Pathophysiology of Pulmonary Hypertension." Chest 105, no. 2 (February 1994): 7S—12S. http://dx.doi.org/10.1378/chest.105.2_supplement.7s.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

Klayton, Ronald J. "PULMONARY PATHOPHYSIOLOGY — THE ESSENTIALS." Military Medicine 158, no. 2 (February 1, 1993): A9. http://dx.doi.org/10.1093/milmed/158.2.a9a.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Shibuya, Kazutoshi, Chikako Hasegawa, Shigeharu Hamatani, Tsutomu Hatori, Tadashi Nagayama, Hiroko Nonaka, Tsunehiro Ando, and Megumi Wakayama. "Pathophysiology of pulmonary aspergillosis." Journal of Infection and Chemotherapy 10, no. 3 (2004): 138–45. http://dx.doi.org/10.1007/s10156-004-0315-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

Matthay, Michael A. "Pathophysiology of Pulmonary Edema." Clinics in Chest Medicine 6, no. 3 (September 1985): 301–14. http://dx.doi.org/10.1016/s0272-5231(21)00366-x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

Stroncek, David. "TRALI Pathophysiology." Blood 114, no. 22 (November 20, 2009): SCI—48—SCI—48. http://dx.doi.org/10.1182/blood.v114.22.sci-48.sci-48.

Texto completo da fonte

Resumo:

Abstract Abstract SCI-48 Transfusion related acute lung injury (TRALI) is clinically defined as the new onset of acute lung injury within 6 hours of a transfusion. In TRALI a transfusion activates neutrophils leading to pulmonary leukostasis, endothelial damage, capillary leak and pulmonary edema. A number of elements (bioactive lipids, sCD40L, and leukocyte antibodies) found in blood products can active neutrophils and are risk factors for TRALI. Bioactive lipids and sCD40L accumulate in both stored red cell and platelet components. Leukocyte antibodies are most often found in blood component

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

Brudno, D. Spencer. "Pulmonary Vascular Physiology and Pathophysiology." Journal of Asthma 27, no. 6 (January 1990): 413–14. http://dx.doi.org/10.3109/02770909009073361.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

Kulik, Thomas J. "Pathophysiology of acute pulmonary vasoconstriction." Pediatric Critical Care Medicine 11 (March 2010): S10—S14. http://dx.doi.org/10.1097/pcc.0b013e3181c766c6.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

Dietz, Niki M. "Pathophysiology of Postpneumonectomy Pulmonary Edema." Seminars in Cardiothoracic and Vascular Anesthesia 4, no. 1 (March 2000): 31–35. http://dx.doi.org/10.1177/108925320000400105.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Jain, Suma, Hector Ventura, and Ben deBoisblanc. "Pathophysiology of Pulmonary Arterial Hypertension." Seminars in Cardiothoracic and Vascular Anesthesia 11, no. 2 (June 2007): 104–9. http://dx.doi.org/10.1177/1089253207301732.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Plovsing, Ronni R., and Ronan M. G. Berg. "Pulmonary Pathophysiology in Another Galaxy." Anesthesiology 120, no. 1 (January 1, 2014): 230–32. http://dx.doi.org/10.1097/aln.0b013e31829c2dfb.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Mason, Carol M., Warren R. Summer, and Steve Nelson. "Pathophysiology of pulmonary defense mechanisms." Journal of Critical Care 7, no. 1 (March 1992): 42–46. http://dx.doi.org/10.1016/0883-9441(92)90007-t.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Genofre, Eduardo Henrique, Francisco S. Vargas, Lisete R. Teixeira, Marcelo Alexandre Costa Vaz, and Evaldo Marchi. "Reexpansion pulmonary edema." Jornal de Pneumologia 29, no. 2 (April 2003): 101–6. http://dx.doi.org/10.1590/s0102-35862003000200010.

Texto completo da fonte

Resumo:

Reexpansion pulmonary edema (RPE) is a rare, but frequently lethal, clinical condition. The precise pathophysiologic abnormalities associated with this disorder are still unknown, though decreased pulmonary surfactant levels and a pro-inflammatory status are putative mechanisms. Early diagnosis is crucial, since prognosis depends on early recognition and prompt treatment. Considering the high mortality rates related to RPE, preventive measures are still the best available strategy for patient handling. This review provides a brief overview of the pathophysiology, diagnosis, treatment, and prev

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Crausman, R. S., C. A. Jennings, R. M. Tuder, L. M. Ackerson, C. G. Irvin, and T. E. King. "Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology." American Journal of Respiratory and Critical Care Medicine 153, no. 1 (January 1996): 426–35. http://dx.doi.org/10.1164/ajrccm.153.1.8542154.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

West, John B. "Internet-based course on pulmonary pathophysiology." Advances in Physiology Education 36, no. 1 (March 2012): 1–2. http://dx.doi.org/10.1152/advan.00125.2011.

Texto completo da fonte

Resumo:

A course of seven video lectures on pulmonary pathophysiology has been placed on the internet. This is a companion to the course on respiratory physiology available at http://meded.ucsd.edu/ifp/jwest/ . That course dealt with normal respiratory physiology, and the new lectures are about the function of the diseased lung. The topics covered include pulmonary function tests, chronic obstructive pulmonary disease, asthma and localized airway obstruction, restrictive lung diseases, pulmonary vascular diseases, environmental or industrial lung diseases (with a short section on neoplastic and infect

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Jonathan, Steven, Triya Damayanti, and Budhi Antariksa. "Pathophysiology of Emphysema." Jurnal Respirologi Indonesia 39, no. 1 (January 2, 2019): 60–69. http://dx.doi.org/10.36497/jri.v39i1.43.

Texto completo da fonte

Resumo:

Pulmonary emphysema is part of pathological condition in chronic obstructive pulmonary disease (COPD) which is characterized by lung parenchymal destruction. Morphology classification of emphysema had been made according to histologic structure in pathology. There were some causes known to be the culprit of emphysema; one that caught most attention is protease-antiprotease activity from cigarette smoke exposure. Destructive effect of emphysema gives disturbance of lung function in expiration (obstruction). The primary mechanism is elastic recoil reduction which causes air trapping, lung volume

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

Humbert, M. "Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology." European Respiratory Review 19, no. 115 (February 28, 2010): 59–63. http://dx.doi.org/10.1183/09059180.00007309.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Lee, Sang-Do. "Pathophysiology of Chronic Obstructive Pulmonary Disease." Journal of the Korean Medical Association 49, no. 4 (2006): 305. http://dx.doi.org/10.5124/jkma.2006.49.4.305.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

Milic-Emili, Joseph, Matteo Pecchiari, and Edgardo D'Angelo. "Pathophysiology of Chronic Obstructive Pulmonary Disease." Current Respiratory Medicine Reviews 4, no. 4 (November 1, 2008): 250–57. http://dx.doi.org/10.2174/157339808786263842.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

Lan, Norris, Benjamin Massam, Sandeep Kulkarni, and Chim Lang. "Pulmonary Arterial Hypertension: Pathophysiology and Treatment." Diseases 6, no. 2 (May 16, 2018): 38. http://dx.doi.org/10.3390/diseases6020038.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

26

Kim, Won Dong. "Pathophysiology of Chronic Obstructive Pulmonary Disease." Tuberculosis and Respiratory Diseases 41, no. 5 (1994): 445. http://dx.doi.org/10.4046/trd.1994.41.5.445.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

27

Kim, Hyun Kuk, and Sang-Do Lee. "Pathophysiology of Chronic Obstructive Pulmonary Disease." Tuberculosis and Respiratory Diseases 59, no. 1 (2005): 5. http://dx.doi.org/10.4046/trd.2005.59.1.5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

28

Lynne-Davies, Patricia. "PULMONARY PATHOPHYSIOLOGY—THE ESSENTIALS, 3rd ed." Chest 92, no. 4 (October 1987): 24. http://dx.doi.org/10.1016/s0012-3692(16)31273-9.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

29

Haas, François, Randi Fain, John Salazar-Schicchi, and Kenneth Axen. "Pathophysiology of Chronic Obstructive Pulmonary Disease." Physical Medicine and Rehabilitation Clinics of North America 7, no. 2 (May 1996): 205–21. http://dx.doi.org/10.1016/s1047-9651(18)30393-0.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

30

Oliveira, Aline C., Elaine M. Richards, and Mohan K. Raizada. "Pulmonary hypertension: Pathophysiology beyond the lung." Pharmacological Research 151 (January 2020): 104518. http://dx.doi.org/10.1016/j.phrs.2019.104518.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

31

O'Donnell, Christopher P., Fernando Holguin, and Anne E. Dixon. "Pulmonary physiology and pathophysiology in obesity." Journal of Applied Physiology 108, no. 1 (January 2010): 197–98. http://dx.doi.org/10.1152/japplphysiol.01208.2009.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

32

NAGAI, SONOKO, and TAKATERU IZUMI. "Pulmonary Sarcoidosis: Population Differences and Pathophysiology." Southern Medical Journal 88, no. 10 (October 1995): 1001–10. http://dx.doi.org/10.1097/00007611-199510000-00002.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

33

Sysol, J. R., and R. F. Machado. "Classification and pathophysiology of pulmonary hypertension." Continuing Cardiology Education 4, no. 1 (June 2018): 2–12. http://dx.doi.org/10.1002/cce2.71.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

34

Gonzalez, Norberto C. "Pulmonary Pathophysiology: The Essentials, 5th Edition." Medicine & Science in Sports & Exercise 31, no. 1 (January 1999): 193–94. http://dx.doi.org/10.1097/00005768-199901000-00043.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

35

Thurlbeck, William M. "Pathophysiology of Chronic Obstructive Pulmonary Disease." Clinics in Chest Medicine 11, no. 3 (September 1990): 389–403. http://dx.doi.org/10.1016/s0272-5231(21)00708-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

36

Simonneau, Gérald, Adam Torbicki, Peter Dorfmüller, and Nick Kim. "The pathophysiology of chronic thromboembolic pulmonary hypertension." European Respiratory Review 26, no. 143 (March 29, 2017): 160112. http://dx.doi.org/10.1183/16000617.0112-2016.

Texto completo da fonte

Resumo:

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive pulmonary vascular disease that is usually a consequence of prior acute pulmonary embolism. CTEPH usually begins with persistent obstruction of large and/or middle-sized pulmonary arteries by organised thrombi. Failure of thrombi to resolve may be related to abnormal fibrinolysis or underlying haematological or autoimmune disorders. It is now known that small-vessel abnormalities also contribute to haemodynamic compromise, functional impairment and disease progression in CTEPH. Small-vessel disease can occur in obstru

Estilos ABNT, Harvard, Vancouver, APA, etc.

37

Shenoy, Vikram, James M. Anton, Charles D. Collard, and Sloan C. Youngblood. "Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension." Anesthesiology 120, no. 5 (May 1, 2014): 1255–61. http://dx.doi.org/10.1097/aln.0000000000000228.

Texto completo da fonte

Resumo:

Abstract Pulmonary thromboendarterectomy is the most effective therapy for chronic thromboembolic pulmonary hypertension. The pathophysiology, anesthetic management, and perioperative outcomes of patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary thromboendarterectomy are reviewed.

Estilos ABNT, Harvard, Vancouver, APA, etc.

38

Widdicombe, J. G. "Nasal pathophysiology." Respiratory Medicine 84 (November 1990): 3–10. http://dx.doi.org/10.1016/s0954-6111(08)80001-7.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

39

Kato, Hideyuki, Yaqin Yana Fu, Jiaquan Zhu, Lixing Wang, Shabana Aafaqi, Otto Rahkonen, Cameron Slorach, et al. "Pulmonary vein stenosis and the pathophysiology of “upstream” pulmonary veins." Journal of Thoracic and Cardiovascular Surgery 148, no. 1 (July 2014): 245–53. http://dx.doi.org/10.1016/j.jtcvs.2013.08.046.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

40

Chuchalin, A. G. "Pulmonary oedema: physiology of lung circulation, pathophysiology of pulmonary oedema." PULMONOLOGIYA, no. 4 (August 28, 2005): 9–18. http://dx.doi.org/10.18093/0869-0189-2005-0-4-9-18.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

41

Amariei, Diana E., Neal Dodia, Janaki Deepak, Stella E. Hines, Jeffrey R. Galvin, Sergei P. Atamas, and Nevins W. Todd. "Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective." Medicina 55, no. 9 (September 10, 2019): 580. http://dx.doi.org/10.3390/medicina55090580.

Texto completo da fonte

Resumo:

Combined pulmonary fibrosis and emphysema (CPFE) has been increasingly recognized over the past 10–15 years as a clinical entity characterized by rather severe imaging and gas exchange abnormalities, but often only mild impairment in spirometric and lung volume indices. In this review, we explore the gas exchange and mechanical pathophysiologic abnormalities of pulmonary emphysema, pulmonary fibrosis, and combined emphysema and fibrosis with the goal of understanding how individual pathophysiologic observations in emphysema and fibrosis alone may impact clinical observations on pulmonary funct

Estilos ABNT, Harvard, Vancouver, APA, etc.

42

Tsuchiya, Nanae, Lindsay Griffin, Hidetake Yabuuchi, Satoshi Kawanami, Jintetsu Shinzato, and Sadayuki Murayama. "Imaging findings of pulmonary edema: Part 1. Cardiogenic pulmonary edema and acute respiratory distress syndrome." Acta Radiologica 61, no. 2 (June 21, 2019): 184–94. http://dx.doi.org/10.1177/0284185119857433.

Texto completo da fonte

Resumo:

Pulmonary edema has many causes; differentiating between these conditions is important. The purpose of this review article is to describe the pathophysiology of pulmonary edema, thereby explaining the imaging findings that differentiate between etiologies. Chest computed tomography provides details on the physiological response and the changes in the anatomical structures of pulmonary edema. An understanding of the pathophysiology underlying the imaging findings facilitates the correct identification of the cause of pulmonary edema.

Estilos ABNT, Harvard, Vancouver, APA, etc.

43

Nelson, Steve, Carol M. Mason, Jay Kolls, and Warren R. Summer. "PATHOPHYSIOLOGY OF PNEUMONIA." Clinics in Chest Medicine 16, no. 1 (March 1995): 1–12. http://dx.doi.org/10.1016/s0272-5231(21)00975-8.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

44

McCool, F. Dennis, and David E. Leith. "Pathophysiology of Cough." Clinics in Chest Medicine 8, no. 2 (June 1987): 189–95. http://dx.doi.org/10.1016/s0272-5231(21)01014-5.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

45

Grissom, Colin K., and Mark R. Elstad. "The pathophysiology of high altitude pulmonary edema." Wilderness & Environmental Medicine 10, no. 2 (June 1999): 88–92. http://dx.doi.org/10.1580/1080-6032(1999)010[0088:tpohap]2.3.co;2.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

46

Browne, George W. "Pathophysiology of pulmonary complications of acute pancreatitis." World Journal of Gastroenterology 12, no. 44 (2006): 7087. http://dx.doi.org/10.3748/wjg.v12.i44.7087.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

47

Rubin, Lewis J. "Pathology and pathophysiology of primary pulmonary hypertension." American Journal of Cardiology 75, no. 3 (January 1995): 51A—54A. http://dx.doi.org/10.1016/s0002-9149(99)80383-x.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

48

Qureshi, Amna Zafar, and Robert M. R. Tulloh. "Paediatric pulmonary hypertension: aetiology, pathophysiology and treatment." Paediatrics and Child Health 27, no. 2 (February 2017): 50–57. http://dx.doi.org/10.1016/j.paed.2016.10.001.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

49

Bärtsch, P. "High-altitude pulmonary oedema: pathophysiology and treatment." European Journal of Anaesthesiology 17, Supplement 20 (2000): 12. http://dx.doi.org/10.1097/00003643-200000003-00023.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

50

Davis, Pamela. "Pathophysiology of Pulmonary Disease in Cystic Fibrosis." Seminars in Respiratory and Critical Care Medicine 6, no. 04 (April 1985): 261–70. http://dx.doi.org/10.1055/s-2007-1011505.

Texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!